Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
Haab BB. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.. Prostate .
Skip to content. | Skip to navigation
 |
Early Detection Research NetworkBiomarkers: the key to early detection |
Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
Haab BB. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.. Prostate . |
|
A Service of the National Cancer Institute
